Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.

BACKGROUND & AIMS In addition to its role as the primary mediator of the enteroinsular axis, glucose-dependent insulinotropic polypeptide (GIP) may play a critical role in the development of obesity. The purpose of these studies was to characterize the effects of GIP and its receptor (GIPR) in adipocyte development and signaling. METHODS Effects of GIP and GIPR on differentiated 3T3-L1 cells were analyzed using Western blot analysis, Oil-Red-O staining, cyclic adenosine monophosphate radioimmunoassay, immunofluorescence microscopy, and glucose uptake measurements. RESULTS To determine whether GIP and GIPR are important components in adipocyte development, the expression profile of GIPR during differentiation was examined. GIPR protein expression was enhanced during the differentiation process, and coincubation with its ligand GIP augmented the expression of aP2, a fat cell marker. Conversely, the suppression of GIPR expression by a specific short hairpin RNA attenuated Oil-Red-O staining and aP2 expression, suggesting that the GIPR may play a critical role in adipocyte development. To investigate specific signaling components that may mediate the effects of GIP, we analyzed Akt, glucose transporter-4, and glucose uptake, all of which are modulated by insulin in fat cells. Like insulin, GIP induced the activation of Akt in a concentration-dependent manner, promoted membrane glucose transporter-4 accumulation, and enhanced [(3)H]-2-deoxyglucose uptake. CONCLUSIONS These studies provide further evidence for an important physiologic role for GIP in lipid homeostasis and possibly in the pathogenesis of obesity. Furthermore, our data indicate that the GIPR might represent a suitable target for the treatment of obesity.

[1]  C. Mcintosh,et al.  Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes , 2007, Journal of Biological Chemistry.

[2]  P. Flatt,et al.  Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice , 2001, Endocrine.

[3]  B. Corkey,et al.  Glucose‐Dependent Insulinotropic Polypeptide Modulates Adipocyte Lipolysis and Reesterification , 2006, Obesity.

[4]  Yuichiro Yamada,et al.  Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action. , 2005, Biochemical and biophysical research communications.

[5]  Roger Y. Tsien,et al.  Insulin disrupts β-adrenergic signalling to protein kinase A in adipocytes , 2005, Nature.

[6]  C. Bailey,et al.  Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes. , 2005, Diabetes.

[7]  C. Mcintosh,et al.  Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression* , 2005, Journal of Biological Chemistry.

[8]  G. Wittert,et al.  Hormonal Changes after Roux-en Y Gastric Bypass for Morbid Obesity and the Control of Type-II Diabetes Mellitus , 2004, The American surgeon.

[9]  Isabel Dominguez,et al.  CK2 Phosphorylation of the Armadillo Repeat Region of β-Catenin Potentiates Wnt Signaling* , 2003, Journal of Biological Chemistry.

[10]  B. Corkey,et al.  Glucose-dependent insulinotropic polypeptide (GIP) promotes triglyceride synthesis in adipocytes , 2003 .

[11]  S. Farmer,et al.  Activation of MEK/ERK Signaling Promotes Adipogenesis by Enhancing Peroxisome Proliferator-activated Receptor γ (PPARγ) and C/EBPα Gene Expression during the Differentiation of 3T3-L1 Preadipocytes* , 2002, The Journal of Biological Chemistry.

[12]  D. Hörsch,et al.  Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. , 2002, The Journal of endocrinology.

[13]  M. Nauck,et al.  Gastric Inhibitory Polypeptide: the neglected incretin revisited , 2002, Regulatory Peptides.

[14]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[15]  Yuichiro Yamada,et al.  Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.

[16]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[17]  M. Birnbaum,et al.  Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice. , 2001, American journal of physiology. Endocrinology and metabolism.

[18]  S. Kersten Mechanisms of nutritional and hormonal regulation of lipogenesis , 2001, EMBO reports.

[19]  S. O’Rahilly,et al.  Arachidonic Acid Stimulates Glucose Uptake in 3T3-L1 Adipocytes by Increasing GLUT1 and GLUT4 Levels at the Plasma Membrane , 2001, The Journal of Biological Chemistry.

[20]  M. Prentki,et al.  Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. , 2001, American journal of physiology. Endocrinology and metabolism.

[21]  L. Orci,et al.  Diseases of liporegulation: new perspective on obesity and related disorders , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  D. Seldin,et al.  Endogenous Protein Kinase CK2 Participates in Wnt Signaling in Mammary Epithelial Cells* , 2000, The Journal of Biological Chemistry.

[23]  M. Wolfe,et al.  Effect of GIP and GLP-1 antagonists on insulin release in the rat. , 1999, American journal of physiology. Endocrinology and metabolism.

[24]  M. Wolfe,et al.  Functional GIP receptors are present on adipocytes. , 1998, Endocrinology.

[25]  M. Carroll,et al.  Overweight and obesity in the United States: prevalence and trends, 1960–1994 , 1998, International Journal of Obesity.

[26]  M. Quon,et al.  Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. , 1997, Molecular endocrinology.

[27]  M. Birnbaum,et al.  Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation* , 1996, The Journal of Biological Chemistry.

[28]  T. Usdin,et al.  Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. , 1996, The Journal of clinical investigation.

[29]  B. Gould,et al.  Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase? , 1995, European journal of clinical nutrition.

[30]  J. Fletcher,et al.  Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue. , 1995, The Journal of nutrition.

[31]  E. Opara,et al.  Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine. , 1995, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.

[32]  D. Smith,et al.  Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.

[33]  M. Wolfe,et al.  Regulation of glucose-dependent insulinotropic peptide gene expression by a glucose meal. , 1994, The American journal of physiology.

[34]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[35]  V. Marks,et al.  Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. , 1991, The Journal of endocrinology.

[36]  J. Deeney,et al.  Cytosolic free calcium in adipocytes. Distinct mechanisms of regulation and effects on insulin action. , 1989, The Journal of biological chemistry.

[37]  G. Glatting,et al.  Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. , 1988, Annals of nutrition & metabolism.

[38]  V. Marks,et al.  Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets. , 1986, Acta endocrinologica.

[39]  C. Kahn,et al.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.

[40]  V. Marks,et al.  Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. , 1984, The Journal of endocrinology.

[41]  V. Grill,et al.  Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat. , 1982, Acta endocrinologica.

[42]  B. Jeanrenaud,et al.  Potential mechanism of insulin action on glucose transport in the isolated rat diaphragm. Apparent translocation of intracellular transport units to the plasma membrane. , 1981, The Journal of biological chemistry.

[43]  S. Cushman,et al.  Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. , 1980, The Journal of biological chemistry.

[44]  R. Eckel,et al.  Gastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes , 1979, Diabetes.

[45]  E. Mazzaferri,et al.  Gastric Inhibitory Polypeptide (GIP) in Maturity-onset Diabetes Mellitus , 1976, Diabetes.

[46]  J. Brown,et al.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man. , 1973, The Journal of clinical endocrinology and metabolism.

[47]  D. Steinberg Hormonal control of lipolysis in adipose tissue. , 1972, Advances in experimental medicine and biology.